ArticleInternational journal of legal medicine2026
Cracking the code of heatstroke: new insights into diagnosis and pathological mechanisms.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As global temperatures continue to rise, the incidence and mortality rates of heatstroke (HS) have significantly increased. However, the current forensic diagnostic standards lack clear pathological criteria for deaths caused by HS, and the mechanisms of multi-organ damage induced by HS are not yet fully understood. In this study, a rat model of HS-induced death was established under conditions of 39 ± 0.5 °C and 60% ± 5% humidity. Through histopathological observation, attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) spectroscopy, and machine learning algorithms, the most severely damaged organs in HS were identified, including the hypothalamus, hippocampus, liver, and spleen. Next, we performed transcriptomic (UID mRNA-seq) and proteomic (Data-Independent Acquisition technology, DIA) analyses on the key target organ-the hypothalamus. Transcriptomic analysis revealed 447 differentially expressed genes (DEGs), with 197 genes upregulated and 250 genes downregulated. Proteomic analysis identified 692 differentially expressed proteins (DEPs), with 241 proteins upregulated and 451 proteins downregulated. Integrated multi-omics analysis indicated significant enrichment of pathways such as endoplasmic reticulum protein processing, MAPK signaling, and apoptosis following HS. Further, three key genes/proteins (Hspb1, Dnaja1, Jun) were identified and their expression changes in the hypothalamus of HS rats were validated using quantitative real-time PCR (qRT-PCR), Western blot, and immunohistochemistry. Overall, this study provides new insights into the diagnosis and mechanisms of HS and offers scientific evidence for the clinical treatment of HS.
Indexed as
Identifiers
42412186What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.